AbbVie
ABBV
#29
Rank
$326.96 B
Marketcap
$185.16
Share price
1.64%
Change (1 day)
30.49%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : $140.82 B

According to AbbVie's latest financial reports the company's total liabilities are $140.82 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$124.31 B2.3%
2022-12-31$121.51 B-7.3%
2021-12-31$131.09 B-4.64%
2020-12-31$137.46 B41.3%
2019-12-31$97.28 B43.5%
2018-12-31$67.79 B3.21%
2017-12-31$65.68 B6.88%
2016-12-31$61.46 B25.17%
2015-12-31$49.10 B90.54%
2014-12-31$25.77 B4.31%
2013-12-31$24.70 B4.49%
2012-12-31$23.64 B211.57%
2011-12-31$7.58 B39.72%
2010-12-31$5.43 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$128.53 B-8.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$82.48 B-41.43%๐Ÿ‡บ๐Ÿ‡ธ USA
$51.04 B-63.75%๐Ÿ‡บ๐Ÿ‡ธ USA
$87.95 B-37.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$38.83 B-72.42%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.35 B-91.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$57.22 B-59.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
$64.79 B-53.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
$1.08 B-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA